Brief: Gt Biopharma Receives Nasdaq Delisting Notice For Falling Below $2.5 Million Equity Minimum

GT Biopharma

27/11/2024 23:15

Nov 27 (Reuters) - GT Biopharma Inc  GTBP.O :
    * GT BIOPHARMA INC - RECEIVES NASDAQ DELISTING NOTICE FOR
FALLING
BELOW $2.5 MILLION EQUITY MINIMUM

Source text:  ID:n0001493152-24-047994 
Further company coverage:  GTBP.O 

 ((Reuters.Briefs@thomsonreuters.com;))